Corona Virus

The Government on Wednesday informed that 559 new positive cases of novel Corona virus (COVID-19),96 from Jammu division and 463 from Kashmir division, have been reported today thus taking the total number of positive cases in Jammu and…

Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 -- ZyCoV-D -- was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from…

A Covid-19 vaccine developed by US-based Novavax elicited robust antibody responses and appeared to be safe in a Phase-I human trial, the company has said.No serious adverse events were reported and safety follow-up continues, Novavax said…

Hyderabad-based Zenara Pharma on Wednesday announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate…

As many as 73 more persons infected with Covid-19 were discharged today after recovery and now the tally of those recovered in the district is 1869.The 73 discharged patients include 26 from Civil Hospital, 22 from Covid Care Centre, 12…

The Government on Tuesday informed that 390 new positive cases of novel Corona virus (COVID-19),152 from Jammu division and 238 from Kashmir division, have been reported today thus taking the total number of positive cases in Jammu and…

JSPL, being an employee-first organisation, today felicitated twenty-five of its outstanding COVID-19 Warriors, who worked round the clock to see that every infected JSPL employee was back in the best of health in the shortest possible…

The Russian Ministry of Defence has said that a Covid-19 vaccine that it developed in partnership with the Gamaleya Scientific Research Institute of Epidemiology and Microbiology appears to be safe.On August 3, a "final medical examination"…

Jubilant Life Sciences Ltd on Monday announced that its subsidiary, Jubilant Generics,has launched remdesivir for injection, under the brand name 'JUBI-R', in the Indian market at a price of Rs 4,700 per vial of 100 mg.The company said it…

Mumbai-headquartered pharmaceutical company Wockhardt on Monday announced that it has entered into an agreement with the UK government to fill-finish millions of doses of Covid-19 vaccines.As per the terms of the agreement, the company has…